Annual D&A
$835.00 K
+$58.00 K+7.46%
31 December 2023
Summary:
Enlivex Therapeutics annual depreciation & amortization is currently $835.00 thousand, with the most recent change of +$58.00 thousand (+7.46%) on 31 December 2023. During the last 3 years, it has risen by +$549.00 thousand (+191.96%). ENLV annual D&A is now at all-time high.ENLV Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$160.00 K
-$28.00 K-14.89%
30 June 2024
Summary:
Enlivex Therapeutics quarterly depreciation & amortization is currently $160.00 thousand, with the most recent change of -$28.00 thousand (-14.89%) on 30 June 2024. Over the past year, it has dropped by -$54.00 thousand (-25.23%). ENLV quarterly D&A is now -27.60% below its all-time high of $221.00 thousand, reached on 31 December 2022.ENLV Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$762.00 K
-$52.00 K-6.39%
30 June 2024
Summary:
Enlivex Therapeutics TTM depreciation & amortization is currently $762.00 thousand, with the most recent change of -$52.00 thousand (-6.39%) on 30 June 2024. Over the past year, it has dropped by -$94.00 thousand (-10.98%). ENLV TTM D&A is now -10.98% below its all-time high of $856.00 thousand, reached on 30 September 2023.ENLV TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENLV Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.5% | -25.2% | -11.0% |
| 3 y3 years | +192.0% | +1.9% | +53.6% |
| 5 y5 years | +590.1% | +226.5% | +316.4% |
ENLV Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +192.0% | -27.6% | +6.7% | -11.0% | +53.6% |
| 5 y | 5 years | at high | +590.1% | -27.6% | +226.5% | -11.0% | +316.4% |
| alltime | all time | at high | -27.6% | -11.0% | >+9999.0% |
Enlivex Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $160.00 K(-14.9%) | $762.00 K(-6.4%) |
| Mar 2024 | - | $188.00 K(-6.0%) | $814.00 K(-2.5%) |
| Dec 2023 | $835.00 K(+7.5%) | $200.00 K(-6.5%) | $835.00 K(-2.5%) |
| Sept 2023 | - | $214.00 K(+0.9%) | $856.00 K(+2.6%) |
| June 2023 | - | $212.00 K(+1.4%) | $834.00 K(+4.5%) |
| Mar 2023 | - | $209.00 K(-5.4%) | $798.00 K(+2.7%) |
| Dec 2022 | $777.00 K(+42.3%) | $221.00 K(+15.1%) | $777.00 K(+10.1%) |
| Sept 2022 | - | $192.00 K(+9.1%) | $706.00 K(+5.2%) |
| June 2022 | - | $176.00 K(-6.4%) | $671.00 K(+8.8%) |
| Mar 2022 | - | $188.00 K(+25.3%) | $617.00 K(+13.0%) |
| Dec 2021 | $546.00 K(+90.9%) | $150.00 K(-4.5%) | $546.00 K(+10.1%) |
| Sept 2021 | - | $157.00 K(+28.7%) | $496.00 K(+20.7%) |
| June 2021 | - | $122.00 K(+4.3%) | $411.00 K(+17.8%) |
| Mar 2021 | - | $117.00 K(+17.0%) | $349.00 K(+22.0%) |
| Dec 2020 | $286.00 K(+38.8%) | $100.00 K(+38.9%) | $286.00 K(+15.3%) |
| Sept 2020 | - | $72.00 K(+20.0%) | $248.00 K(+10.2%) |
| June 2020 | - | $60.00 K(+11.1%) | $225.00 K(+4.2%) |
| Mar 2020 | - | $54.00 K(-12.9%) | $216.00 K(+4.9%) |
| Dec 2019 | $206.00 K | $62.00 K(+26.5%) | $206.00 K(+12.6%) |
| Sept 2019 | - | $49.00 K(-3.9%) | $183.00 K(+13.7%) |
| June 2019 | - | $51.00 K(+15.9%) | $161.00 K(+22.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $44.00 K(+12.8%) | $132.00 K(+9.1%) |
| Dec 2018 | $121.00 K(+45.8%) | $39.00 K(+44.4%) | $121.00 K(+19.8%) |
| Sept 2018 | - | $27.00 K(+22.7%) | $101.00 K(+36.5%) |
| June 2018 | - | $22.00 K(-33.3%) | $74.00 K(-33.3%) |
| Mar 2018 | - | $33.00 K(+73.7%) | $111.00 K(+33.7%) |
| Dec 2017 | $83.00 K(+118.4%) | $19.00 K(>+9900.0%) | $83.00 K(0.0%) |
| Sept 2017 | - | $0.00(-100.0%) | $83.00 K(-6.7%) |
| June 2017 | - | $59.00 K(+1080.0%) | $89.00 K(+140.5%) |
| Mar 2017 | - | $5000.00(-73.7%) | $37.00 K(-2.6%) |
| Dec 2016 | $38.00 K(+123.5%) | $19.00 K(+216.7%) | $38.00 K(+46.2%) |
| Sept 2016 | - | $6000.00(-14.3%) | $26.00 K(+8.3%) |
| June 2016 | - | $7000.00(+16.7%) | $24.00 K(+20.0%) |
| Mar 2016 | - | $6000.00(-14.3%) | $20.00 K(+17.6%) |
| Dec 2015 | $17.00 K(+240.0%) | $7000.00(+75.0%) | $17.00 K(+41.7%) |
| Sept 2015 | - | $4000.00(+33.3%) | $12.00 K(+20.0%) |
| June 2015 | - | $3000.00(0.0%) | $10.00 K(+42.9%) |
| Mar 2015 | - | $3000.00(+50.0%) | $7000.00(+40.0%) |
| Dec 2014 | $5000.00(>+9900.0%) | $2000.00(0.0%) | $5000.00(+66.7%) |
| Sept 2014 | - | $2000.00(>+9900.0%) | $3000.00(+200.0%) |
| June 2014 | - | $0.00(-100.0%) | $1000.00(0.0%) |
| Mar 2014 | - | $1000.00 | $1000.00 |
| Dec 2012 | $0.00 | - | - |
FAQ
- What is Enlivex Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual D&A year-on-year change?
- What is Enlivex Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly D&A year-on-year change?
- What is Enlivex Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Enlivex Therapeutics?
- What is Enlivex Therapeutics TTM D&A year-on-year change?
What is Enlivex Therapeutics annual depreciation & amortization?
The current annual D&A of ENLV is $835.00 K
What is the all time high annual D&A for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual depreciation & amortization is $835.00 K
What is Enlivex Therapeutics annual D&A year-on-year change?
Over the past year, ENLV annual depreciation & amortization has changed by +$58.00 K (+7.46%)
What is Enlivex Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of ENLV is $160.00 K
What is the all time high quarterly D&A for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly depreciation & amortization is $221.00 K
What is Enlivex Therapeutics quarterly D&A year-on-year change?
Over the past year, ENLV quarterly depreciation & amortization has changed by -$54.00 K (-25.23%)
What is Enlivex Therapeutics TTM depreciation & amortization?
The current TTM D&A of ENLV is $762.00 K
What is the all time high TTM D&A for Enlivex Therapeutics?
Enlivex Therapeutics all-time high TTM depreciation & amortization is $856.00 K
What is Enlivex Therapeutics TTM D&A year-on-year change?
Over the past year, ENLV TTM depreciation & amortization has changed by -$94.00 K (-10.98%)